
A Phase zzso clinical trial of zzso zzso capture therapy zzso for zzso zzso is zzso using the zzso acid analog zzso zzso and the zzso zzso beam at the zzso Medical Research zzso zzso studies were carried out in 18 patients at the time of zzso using an zzso infusion of zzso zzso as a zzso complex zzso There were no toxic effects related to the zzso administration at doses of zzso zzso 210, or 250 zzso zzso body zzso The zzso blood, zzso and zzso zzso concentration ratios were approximately zzso zzso and zzso zzso Ten patients have received zzso following zzso infusions of 250 zzso zzso body zzso The average zzso concentration in the blood during the zzso was zzso zzso zzso zzso zzso The prescribed maximum dose to normal brain (1 zzso zzso was zzso zzso zzso zzso zzso maximum and minimum doses zzso zzso zzso zzso zzso 10) to the tumor volume were zzso zzso zzso zzso zzso zzso and zzso zzso zzso zzso zzso zzso zzso The estimated minimum dose to the target volume zzso zzso zzso zzso was zzso zzso zzso zzso zzso zzso There were no adverse effects on normal zzso The scalp showed mild zzso followed by zzso in the 8 zzso diameter zzso Four patients developed zzso zzso apparently in the lower dose zzso regions of the target volume, at zzso intervals of zzso and 3 months, zzso The remaining patients have had less than 4 months of zzso zzso zzso at this starting dose level, appears zzso Plans are zzso to begin the dose escalation phase of this zzso 

